Trial NCT03135262

View at ClinicalTrials.gov 
Org. Study IDs: BH39147
Secondary IDs: 2016-002480-34

Last trial update was posted on 2021-12-07

MeSH Interventions

Obinutuzumab Rituximab Venetoclax

MeSH Conditions

Lymphoma Lymphoma, Follicular Lymphoma, Large B-Cell, Diffuse

Other Conditions

Follicular Lymphoma

Stopping Reasons

Sponsor's decision to terminate the study after Phase 1; will not proceed with Phase 2.

Limitations And Caveats

Dose expansion part of the study did not take place. AEs were not differentiated for DLBCL and FL arms since these are sub mutations of disease which does nor show differences in AEs.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID